Michele Masucci

About me
Publications
Grants
CV
Public outreach and news

About me

I'm a PhD candidate at Karolinska Institutet (KI) in Stockholm, where belog to the Department of Microbiology, Tumor, and Cell Biology (MTC) and the Department of Learning, Informatics, Managment and Ethics (LIME). I have over fourteen years of experience with supporting translational projects related to Personalized Cancer Medicine at Karolinska Institutet and with Cancer Core Europe through the PCM Program. My research is focused on understanding the organisational aspects that condition the translational research processes.

Research

I work with scientific studies of organizational determinants for the translation of Personalized Cancer Medicine.

Selected publications

Review: JOURNAL OF PERSONALIZED MEDICINE. 2024;14(6):561
Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine
Masucci M; Karlsson C; Blomqvist L; Ernberg I

Articles

Article: NATURE CANCER. 2022;3(2):251-261
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
Tamborero D; Dienstmann R; Rachid MH; Boekel J; Lopez-Fernandez A; Jonsson M; Razzak A; Brana I; De Petris L; Yachnin J; Baird RD; Loriot Y; Massard C; Martin-Romano P; Opdam F; Schlenk RF; Vernieri C; Masucci M; Villalobos X; Chavarria E; Balmana J; Apolone G; Caldas C; Bergh J; Ernberg I; Frohling S; Garralda E; Karlsson C; Tabernero J; Voest E; Rodon J; Lehtio J
Article: RADIOTHERAPY AND ONCOLOGY. 2014;113(3):303-309
Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets
Skripcak T; Belka C; Bosch W; Brink C; Brunner T; Budach V; Buettner D; Debus J; Dekker A; Grau C; Gulliford S; Hurkmans C; Just U; Krause M; Lambin P; Langendijk JA; Lewensohn R; Luehr A; Maingon P; Masucci M; Niyazi M; Poortmans P; Simon M; Schmidberger H; Spezi E; Stuschke M; Valentini V; Verheij M; Whitfield G; Zackrisson B; Zips D; Baumann M
Article: CELLULAR MICROBIOLOGY. 2010;12(11):1622-1633
The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton
Basseres E; Coppotelli G; Pfirrmann T; Andersen JB; Masucci M; Frisan T
Article: IMMUNOLOGY. 2010;129(3):386-395
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope
Marescotti D; Destro F; Baldisserotto A; Marastoni M; Coppotelli G; Masucci M; Gavioli R
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;68(6):579-588
Inhibition of Serine-Peptidase Activity Enhances the Generation of a Survivin-Derived HLA-A2-Presented CTL Epitope in Colon-Carcinoma Cells
Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2007;56(10):1597-1604
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Liu J-Y; Wu Y; Zhang X-S; Yang J-L; Li H-L; Mao Y-Q; Wang Y; Cheng X; Li Y-Q; Xia J-C; Masucci M; Zeng Y-X
Article: NATURE MEDICINE. 2004;10(12):1321-1328
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
Issaeva N; Bozko P; Enge M; Protopopova M; Verhoef LGGC; Masucci M; Pramanik A; Selivanova G
Article: METHODS IN MOLECULAR BIOLOGY. 2001;174:213-216
Limiting dilution assay.
Frisan T; Levitsky V; Masucci M
Article: METHODS IN MOLECULAR BIOLOGY. 2001;174:209-211
Determination of antigen and fine peptide specificity of EBV-specific CTLs.
Levitsky V; Frisan T; Masucci M
Article: METHODS IN MOLECULAR BIOLOGY. 2001;174:203-208
Generation of polyclonal EBV-specific CTL cultures and clones.
Levitsky V; Frisan T; Masucci M
Article: METHODS IN MOLECULAR BIOLOGY. 2001;174:199-201
Regression assay.
Frisan T; Levitsky V; Masucci M
Article: METHODS IN MOLECULAR BIOLOGY. 2001;174:125-127
Generation of lymphoblastoid cell lines (LCLs).
Frisan T; Levitsky V; Masucci M

All other publications

Preprint: PREPRINTS.ORG. 2024
Bridging the Divide – a Review on the Implementation of Personalized Cancer Medicine
Masucci M; Ernberg I; Karlsson C; Blomqvist LB
Corrigendum: NATURE CANCER. 2022;3(5):649
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (vol 3, pg 251, 2022)
Tamborero D; Dienstmann R; Rachid MH; Boekel J; Lopez-Fernandez A; Jonsson M; Razzak A; Brana I; De Petris L; Yachnin J; Baird RD; Loriot Y; Massard C; Martin-Romano P; Opdam F; Schlenk RF; Vernieri C; Masucci M; Villalobos X; Chavarria E; Balmana J; Apolone G; Caldas C; Bergh J; Ernberg I; Frohling S; Garralda E; Karlsson C; Tabernero J; Voest E; Rodon J; Lehtio J
Preprint: RESEARCH SQUARE. 2021
Implementation of a Clinical Decision Support System for Precision Oncology across an Academic Network
Tamborero D; Dienstmann R; Rachid M; Boekel J; Lopez-Fernandez A; Braña I; De Petris L; Yachnin J; Baird R; Massard C; Opdam F; Schlenk R; Vernieri C; Masucci M; Villalobos X; Chavarria E; Balmaña J; Apolone G; Caldas C; Bergh J; Ernberg I; Fröhling S; Garralda E; Karlsson C; Tabernero J; Voest E; Rodon J; Lehtiö J
Letter: NATURE MEDICINE. 2020;26(7):992-994
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
Tamborero D; Dienstmann R; Rachid MH; Boekel J; Baird R; Brana I; De Petris L; Yachnin J; Massard C; Opdam FL; Schlenk R; Vernieri C; Garralda E; Masucci M; Villalobos X; Chavarria E; Calvo F; Frohling S; Eggermont A; Apolone G; Voest EE; Caldas C; Tabernero J; Ernberg I; Rodon J; Lehtio J
Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2006;64(6):581-587
Is the activity of partially agonistic MHC:Peptide ligands dependent on the quality of immunological help?
Uhlin M; Masucci M; Levitsky V

Selected grants

PCM Program
Radium Hemmets Research Funds

Employments

Phd Student, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2025-2025
Phd Student, Medical Management, Department of Learning, Informatics, Ethics and Management, Karolinska Institutet, 2016-2025
Scientific Coordinator, Personalized Cancer Medicine, Radiumhemmets Research Funds, 2014-2025

About me

Research

Selected publications

Articles

All other publications

Selected grants

Employments

News from KI

Events from KI